BR112015000665A2 - método para a determinação da quantidade de um anticorpo - Google Patents

método para a determinação da quantidade de um anticorpo

Info

Publication number
BR112015000665A2
BR112015000665A2 BR112015000665A BR112015000665A BR112015000665A2 BR 112015000665 A2 BR112015000665 A2 BR 112015000665A2 BR 112015000665 A BR112015000665 A BR 112015000665A BR 112015000665 A BR112015000665 A BR 112015000665A BR 112015000665 A2 BR112015000665 A2 BR 112015000665A2
Authority
BR
Brazil
Prior art keywords
antibody
determining
amount
Prior art date
Application number
BR112015000665A
Other languages
English (en)
Inventor
Stubenrauch Kay-Gunnar
Zadak Markus
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR112015000665A2 publication Critical patent/BR112015000665A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
BR112015000665A 2012-07-13 2013-07-11 método para a determinação da quantidade de um anticorpo BR112015000665A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12176342 2012-07-13
PCT/EP2013/064683 WO2014009474A1 (en) 2012-07-13 2013-07-11 Method for the detection of a multispecific binder

Publications (1)

Publication Number Publication Date
BR112015000665A2 true BR112015000665A2 (pt) 2017-06-27

Family

ID=48782335

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015000665A BR112015000665A2 (pt) 2012-07-13 2013-07-11 método para a determinação da quantidade de um anticorpo

Country Status (12)

Country Link
US (1) US9488662B2 (pt)
EP (1) EP2872893B1 (pt)
JP (1) JP6226976B2 (pt)
KR (1) KR20150038046A (pt)
CN (1) CN104471397B (pt)
BR (1) BR112015000665A2 (pt)
CA (1) CA2873829A1 (pt)
ES (1) ES2627482T3 (pt)
HK (1) HK1208731A1 (pt)
MX (1) MX346146B (pt)
RU (1) RU2636822C2 (pt)
WO (1) WO2014009474A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2620563C2 (ru) 2012-02-01 2017-05-26 Ф. Хоффманн-Ля Рош Аг Способ детекции партнера по связыванию мультиспецифического связывающего агента
JP6446044B2 (ja) * 2013-11-05 2018-12-26 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 結合分子の存在下で被検体の総量および／または総濃度を決定するための方法、ならびにそれに関係するキット、組成物および使用
EP3136096B1 (en) 2014-04-23 2021-12-01 Nichirei Biosciences Inc. Combination for target marker detection
AU2016344665C1 (en) * 2015-10-29 2023-07-27 F. Hoffmann-La Roche Ag Anti-variant Fc-region antibodies and methods of use
BR112018008789A2 (pt) * 2015-11-30 2018-10-30 F. Hoffmann-La Roche Ag método para a determinação da quantidade de um anticorpo bivalente em uma amostra de soro ou plasma
WO2019235420A1 (ja) 2018-06-04 2019-12-12 中外製薬株式会社 複合体を検出する方法
EP3969907A1 (en) * 2019-05-13 2022-03-23 F. Hoffmann-La Roche AG Interference-suppressed pharmacokinetic immunoassay

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219730A (en) 1982-09-28 1993-06-15 New York University Idiotype-anti-idiotype immunoassay
US4828981A (en) 1983-08-24 1989-05-09 Synbiotics Corporation Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents
EP0170302A1 (fr) 1984-06-27 1986-02-05 l'Association internationale à but scientifique, dite: Institut international de pathologie cellulaire et moléculaire Procédé de dosage immunologique d'une substance dans un échantillon liquide au moyen d'anticorps anti-idiotypiques
US5238808A (en) 1984-10-31 1993-08-24 Igen, Inc. Luminescent metal chelate labels and means for detection
EP0243471A4 (en) 1985-10-22 1989-07-11 Cooper Lipotech Inc SOLID PHASE LIPOSOME IMMUNOANALYSIS SYSTEM.
US5068088A (en) 1988-11-03 1991-11-26 Igen, Inc. Method and apparatus for conducting electrochemiluminescent measurements
SG60022A1 (en) 1988-11-03 1999-02-22 Igen Inc Electrochemicalmiliuminescent assays
IL100866A (en) 1991-02-06 1995-10-31 Igen Inc Luminescence test method and device based on magnetic tiny particles, containing many magnets
DK0651761T3 (da) 1992-07-13 2003-02-10 Bionebraska Inc Fremgangsmåde til modifikation af rekombinante polypeptider
GB9316369D0 (en) 1993-08-06 1993-09-22 Surface Active Ltd Diagnostic method
US6753189B1 (en) 1998-06-04 2004-06-22 Mizuho Medy Co., Ltd. Detection apparatus and method for the same
AU774575C (en) 1999-11-16 2005-09-08 Genentech Inc. Elisa for VEGF
DE60233744D1 (de) 2001-09-20 2009-10-29 Univ Texas Bestimmung der zirkulierenden therapeutischen antikörper, antigene sowie antigen-antikörper-komplexe mit elisa-tests
US20080206782A1 (en) 2005-03-08 2008-08-28 Genentech, Inc. Methods for Determining the Bivalency of Protein and Antibody Therapeutics
PT2069798E (pt) 2006-10-04 2014-06-24 Genentech Inc Elisa para vegf
EP1917854A1 (en) 2006-11-06 2008-05-07 F. Hoffmann-La Roche Ag Method for producing anti idiotypic antibodies
AU2008234248C1 (en) 2007-03-29 2015-01-22 Genmab A/S Bispecific antibodies and methods for production thereof
TWI570135B (zh) * 2007-04-27 2017-02-11 建南德克公司 高效、穩定且非免疫抑制之抗－ｃｄ４抗體
US9266967B2 (en) 2007-12-21 2016-02-23 Hoffmann-La Roche, Inc. Bivalent, bispecific antibodies
US20090162359A1 (en) 2007-12-21 2009-06-25 Christian Klein Bivalent, bispecific antibodies
US8227577B2 (en) 2007-12-21 2012-07-24 Hoffman-La Roche Inc. Bivalent, bispecific antibodies
US8242247B2 (en) 2007-12-21 2012-08-14 Hoffmann-La Roche Inc. Bivalent, bispecific antibodies
WO2010042031A1 (en) * 2008-10-07 2010-04-15 Gyros Patent Ab Semi-sequential assay for detection of an analyte in a sample
US8268314B2 (en) * 2008-10-08 2012-09-18 Hoffmann-La Roche Inc. Bispecific anti-VEGF/anti-ANG-2 antibodies
CN102369215B (zh) 2009-04-02 2015-01-21 罗切格利卡特公司 包含全长抗体和单链Fab片段的多特异性抗体
PT2417156E (pt) 2009-04-07 2015-04-29 Roche Glycart Ag Anticorpos trivalentes, biespecíficos
SG176219A1 (en) 2009-05-27 2011-12-29 Hoffmann La Roche Tri- or tetraspecific antibodies
US9676845B2 (en) 2009-06-16 2017-06-13 Hoffmann-La Roche, Inc. Bispecific antigen binding proteins
US8703132B2 (en) 2009-06-18 2014-04-22 Hoffmann-La Roche, Inc. Bispecific, tetravalent antigen binding proteins
CN102207504A (zh) 2011-03-23 2011-10-05 北京华创远航科技有限公司 一种酶联检测试剂盒及其制备方法
CN104040350B (zh) 2011-12-19 2016-05-18 弗·哈夫曼-拉罗切有限公司 用于检测多特异性结合物的游离结合搭档的方法
RU2620563C2 (ru) 2012-02-01 2017-05-26 Ф. Хоффманн-Ля Рош Аг Способ детекции партнера по связыванию мультиспецифического связывающего агента

Also Published As

Publication number Publication date
MX2014014566A (es) 2015-02-20
EP2872893A1 (en) 2015-05-20
US20150198608A1 (en) 2015-07-16
JP2015522171A (ja) 2015-08-03
WO2014009474A1 (en) 2014-01-16
US9488662B2 (en) 2016-11-08
RU2636822C2 (ru) 2017-11-28
MX346146B (es) 2017-03-09
KR20150038046A (ko) 2015-04-08
CN104471397A (zh) 2015-03-25
CA2873829A1 (en) 2014-01-16
HK1208731A1 (en) 2016-03-11
RU2015104737A (ru) 2016-08-27
CN104471397B (zh) 2018-03-23
ES2627482T3 (es) 2017-07-28
EP2872893B1 (en) 2017-03-29
JP6226976B2 (ja) 2017-11-08

Similar Documents

Publication Publication Date Title
CR20130677A (es) FORMULACIÓN PARA ANTICUERPO ANTI-a4ß7
DK2934584T3 (da) Anti-gdf15-antistoffer
CO6811812A2 (es) Anticuerpo anti-b7-h3
BR112014021742A2 (pt) métodos para determinar opticamente uma característica de uma substância
BR112014021741A2 (pt) métodos para determinar opticamente uma característica de uma substância
DK2850101T3 (da) Anti-FcRn-antistoffer
DK2858671T3 (da) Antistofformulering
CO7020871A2 (es) Anticuerpos anti-il-36r
BR112014001004A2 (pt) método para determinar a condição operacional futura de um objeto
CO7020864A2 (es) Polipéptidos de anticuerpos que antagonizan cd40 l
CO7020875A2 (es) Anticuerpos humanizados que reconocen la alfa-sinucleina
BR112014021740A2 (pt) dispositivos para determinar opticamente de uma característica de uma substância
DK2890397T3 (da) Antiprolactinreceptor-antistofformulering
DK2776833T3 (da) Cobinder-understøttet testfremgangsmåde
BR112014011900A2 (pt) um método de purificação de anticorpo
CR20140127A (es) Anticuerpo anti-abtcr
BR112014013034A2 (pt) método para produzir um anticorpo
CL2015000158A1 (es) Metodo para la manipulacion de aguacates
BR112015022106A2 (pt) método para determinar uma propriedade de uma formação
BR112014025037A2 (pt) anticorpo ou um fragmento funcional do mesmo, nucleotídeo, vetor recombinante, célula, métodos para a produção de um anticorpo ou fragmento funcional, para detecção ou ensaio de fgfr2 humano iiib, para a identificação de um indivíduo receptor de uma composição farmacêutica, e, para identificar e para produzir uma substância, forma modificada, composição, e, reagente
BR112015000665A2 (pt) método para a determinação da quantidade de um anticorpo
DK3332813T3 (da) Metode til opregulering af antigenekspression
BR112014014706A2 (pt) método e disposição para testar a funcionalidade apropriada de um elevador
FI20125280L (fi) Menetelmä ja järjestely liikkuvan kohteen käyttäytymisen erittelemiseksi
BR112014024458A2 (pt) método para identificar uma composição líquida.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B06I Technical and formal requirements: publication cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07D Technical examination (opinion) related to article 229 of industrial property law

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa)
B06U Preliminary requirement: requests with searches performed by other patent offices: suspension of the patent application procedure
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 7A ANUIDADE.

B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements